Stocks
Bluebird Bio (BLUE) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 763.8% | 2 028% | 1 391% | 1 823% | 1 851% | 1 463% | |||
| Changes by years, y/y, % | -41pp | +1 265pp | -638pp | +432pp | +28pp | +18.1% | |||
Bluebird Bio. R&D/CAPEX, %
Bluebird Bio. R&D/CAPEX, changes, pp
Bluebird Bio (BLUE) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 2 231% | 1 413% | 647.7% | 42 647% | 8 276% | 1 463% | ||
| Changes by years, y/y, % | -1 974pp | -2 782pp | -251pp | +36 651pp | +6 046pp | |||
| Changes by quarters, q/q, % | -3 766pp | -818pp | -765pp | +42 000pp | -34 371pp | |||
